Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sandoz’s Saynor: ‘Everyone’s Asking The Wrong Questions’ On GLP-1s
CEO Points To Manufacturing Capacity, Not Size Of Market, As Key Consideration
Nov 25 2025
•
By
Dave Wallace
Many unknowns remain when it comes to the generic GLP-1 opportunity
(Shutterstock)
More from Generics
More from Products